Michael T. Spiotto

5.0k total citations · 1 hit paper
99 papers, 3.8k citations indexed

About

Michael T. Spiotto is a scholar working on Oncology, Otorhinolaryngology and Surgery. According to data from OpenAlex, Michael T. Spiotto has authored 99 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Oncology, 34 papers in Otorhinolaryngology and 29 papers in Surgery. Recurrent topics in Michael T. Spiotto's work include Head and Neck Cancer Studies (34 papers), Head and Neck Surgical Oncology (19 papers) and Immunotherapy and Immune Responses (10 papers). Michael T. Spiotto is often cited by papers focused on Head and Neck Cancer Studies (34 papers), Head and Neck Surgical Oncology (19 papers) and Immunotherapy and Immune Responses (10 papers). Michael T. Spiotto collaborates with scholars based in United States, Canada and Australia. Michael T. Spiotto's co-authors include Ralph R. Weichselbaum, Theodore D. Chung, Yang‐Xin Fu, Hans Schreiber, Donald A. Rowley, Matthew Koshy, Christopher King, Jianqing Yu, Wenbin Lin and Kaiyuan Ni and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Michael T. Spiotto

96 papers receiving 3.8k citations

Hit Papers

Low-dose X-ray radiotherapy–radiodynamic therapy via nano... 2018 2026 2020 2023 2018 100 200 300 400 500

Peers

Michael T. Spiotto
Eun Kyung Choi South Korea
Christina S. Kong United States
Steven J. Chmura United States
Stephan Bodis Switzerland
Michael T. Spiotto
Citations per year, relative to Michael T. Spiotto Michael T. Spiotto (= 1×) peers Luitpold Distel

Countries citing papers authored by Michael T. Spiotto

Since Specialization
Citations

This map shows the geographic impact of Michael T. Spiotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael T. Spiotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael T. Spiotto more than expected).

Fields of papers citing papers by Michael T. Spiotto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael T. Spiotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael T. Spiotto. The network helps show where Michael T. Spiotto may publish in the future.

Co-authorship network of co-authors of Michael T. Spiotto

This figure shows the co-authorship network connecting the top 25 collaborators of Michael T. Spiotto. A scholar is included among the top collaborators of Michael T. Spiotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael T. Spiotto. Michael T. Spiotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cabanillas, Maria E., Naifa L. Busaidy, G. Brandon Gunn, et al.. (2025). Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer. Thyroid. 35(7). 763–770. 1 indexed citations
2.
Nguyen, Callistus, Steven J. Frank, Adam S. Garden, et al.. (2024). Clinical acceptability of automatically generated lymph node levels and structures of deglutition and mastication for head and neck radiation therapy. Physics and Imaging in Radiation Oncology. 29. 100540–100540. 2 indexed citations
3.
DeMonte, Franco, Theresa Nguyen, Adam S. Garden, et al.. (2024). A prospective cohort study on stereotactic radiotherapy in the management of dural recurrence of olfactory neuroblastoma. Head & Neck. 47(1). 81–89. 1 indexed citations
4.
Rooney, Michael K., Kelsey L. Corrigan, Vincent Bernard, et al.. (2023). Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio. Cancers. 15(17). 4321–4321. 10 indexed citations
5.
Contrera, Kevin J., Jack Phan, Steven G. Waguespack, et al.. (2023). Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies. Head & Neck. 45(10). 2525–2532. 1 indexed citations
6.
Strati, Paolo & Michael T. Spiotto. (2023). Incorporating Immunotherapy with Radiotherapy for Lymphomas. PubMed. 1(3). 273–286. 1 indexed citations
8.
Korpics, Mark, et al.. (2021). Impact of anatomic site of distant metastasis on survival in salivary gland cancers. Head & Neck. 43(9). 2589–2601. 3 indexed citations
10.
Foster, Corey C., David J. Sher, Chad G. Rusthoven, et al.. (2019). Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis. Radiation Oncology. 14(1). 18–18. 38 indexed citations
12.
Lu, Kuangda, Chunbai He, Nining Guo, et al.. (2018). Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy. Nature Biomedical Engineering. 2(8). 600–610. 518 indexed citations breakdown →
13.
Spiotto, Michael T., Gina D. Jefferson, Barry L. Wenig, et al.. (2017). Survival outcomes for postoperative chemoradiation in intermediate‐risk oral tongue cancers. Head & Neck. 39(12). 2537–2548. 11 indexed citations
14.
Bechill, John, et al.. (2016). A High-Throughput Cell-Based Screen Identified a 2-[(E)-2-Phenylvinyl]-8-Quinolinol Core Structure That Activates p53. PLoS ONE. 11(4). e0154125–e0154125. 4 indexed citations
15.
Bao, Riyue, Pieter Faber, Vytautas P. Bindokas, et al.. (2015). Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis. Cancer Research. 75(18). 3958–3969. 24 indexed citations
16.
Bechill, John, et al.. (2015). Loss of E2F1 Extends Survival and Accelerates Oral Tumor Growth in HPV-Positive Mice. Cancers. 7(4). 2372–2385. 6 indexed citations
17.
Pelizzari, Charles A., et al.. (2014). Bioluminescent Imaging of HPV-Positive Oral Tumor Growth and Its Response to Image-Guided Radiotherapy. Cancer Research. 74(7). 2073–2081. 19 indexed citations
18.
Koshy, Matthew, David J. Sher, Michael T. Spiotto, et al.. (2014). The Effect of Radiotherapy Dose on Survival in Stage III Non–Small-Cell Lung Cancer Patients Undergoing Definitive Chemoradiotherapy. Clinical Lung Cancer. 15(5). 365–371. 9 indexed citations
19.
Schreiber, Karin, Ainhoa Arina, Boris Engels, et al.. (2012). Spleen Cells from Young but Not Old Immunized Mice Eradicate Large Established Cancers. Clinical Cancer Research. 18(9). 2526–2533. 21 indexed citations
20.
Fels, Diane, Jiangbin Ye, Steven J. Kridel, et al.. (2008). Preferential Cytotoxicity of Bortezomib toward Hypoxic Tumor Cells via Overactivation of Endoplasmic Reticulum Stress Pathways. Cancer Research. 68(22). 9323–9330. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026